Cadence Biomedical Closes Oversubscribed $1.1 Million Series A2

SEATTLE--(BUSINESS WIRE)--Cadence Biomedical, a provider of medical devices that help people with severe disabilities walk, announced the closing of an oversubscribed $1.1 million Series A2 financing led by HealthTech Capital. Other investors include Sand Hill Angels, Tech Coast Angels, ACE Fund, Frontier Angel Fund, WINGS, Alliance of Angels, and Keiretsu Forum Northwest. The financing will support manufacturing and sales as Cadence releases its revolutionary Kickstart™ Kinetic Orthosis to the market.